Devnath GP, Kumaran S, Rajiv R, Shaha KK, Nagaraj A
DSIP had no effect on somatotrope and corticotrope differentiation
Disclosures: Stefano D'Anna: Nothing to Disclose, Romina Salpini: Nothing to Disclose, Elisabetta Degasperi: Gilead: Speaking and Teaching, Roche: Advisor, Abbvie: Speaking and Teaching, Leonardo Duca: Nothing to Disclose, Maria Paola Anolli: Nothing to Disclose, Lorenzo Piermatteo: Nothing to Disclose, Dana Sambarino: Nothing to Disclose, Marta Borghi: Nothing to Disclose, Francesca Ceccherini Silberstein: Nothing to Disclose, Floriana Facchetti: Nothing to Disclose, Riccardo Perbellini: Nothing to Disclose, valentina svicher: Nothing to Disclose, Pietro Lampertico: ROCHE PHARMA/DIAGNOSTICS, GILEAD SCIENCES, GSK, ABBVIE, JANS: Advisor 884 GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA Mario Alvares-da-Silva 1 Cassio Perlin 1 Melina Keingeski 1 Bruno Basso 1 Juliane Medeiros 2 Francis Borges 2 Carolina Uribe-Cruz 3 , 1 Universidade Federal do Rio Grande do Sul, 2 Universidade Federal de Juiz de Fora, 3 Universidad Catolica de Misiones Background: Gut microbiome (GM) dysbiosis is associated with the development and progression of metabolic-dysfunction associated steatotic liver disease (MASLD) and steatohepatitis (MASH)
383 When sepsis keeps progressing, it may induce septic shock, multiple organ failure, and even death
The calcium image was then spatially downsampled by a factor of nine and cropped into 180 180 pixels
